Table of Contents

Feature Articles

• You have accessRestricted Access

  A Culturally Tailored Community Health Worker Intervention Leads to Improvement in Patient-Centered Outcomes for Immigrant Patients With Type 2 Diabetes

  Nadia S. Islam, Laura C. Wyatt, M.D. Taher, Lindsey Riley, S. Darius Tandon, Michael Tanner, B. Runi Mukherji and Chau Trinh-Shevrin

  Clinical Diabetes 2018 Apr; 36 (2): 100-111. https://doi.org/10.2337/cd17-0068

  Add to Selected Citations
• You have accessRestricted Access

  Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes

  Ava S. Runge, Lynn Kennedy, Adam S. Brown, Abigail E. Dove, Brian J. Levine, Sophie P. Koontz, Varun S. Iyengar, Sarah A. Odeh, Kelly L. Close, Irl B. Hirsch and Richard Wood

  Clinical Diabetes 2018 Apr; 36 (2): 112-119. https://doi.org/10.2337/cd17-0094

  Add to Selected Citations
• You have accessRestricted Access

  Using Shared Decision-Making to Address Possible Overtreatment in Patients at High Risk for Hypoglycemia: The Veterans Health Administration’s Choosing Wisely Hypoglycemia Safety Initiative

  Samantha M. Wright, Sandra C. Hedin, Mark McConnell, Brian V. Burke, Sharon A. Watts, Donna M. Leslie, David C. Aron and Leonard M. Pogach

  Clinical Diabetes 2018 Apr; 36 (2): 120-127. https://doi.org/10.2337/cd17-0060

  Add to Selected Citations
• You have accessRestricted Access

  The Effect of Elevated A1C on Immediate Postoperative Complications: A Prospective Observational Study

  Pinxia Chen, Katherine K. Hallock, Christie L. Mulvey, Arthur S. Berg and Verghese T. Cherian

  Clinical Diabetes 2018 Apr; 36 (2): 128-132. https://doi.org/10.2337/cd17-0081

  Add to Selected Citations
• You have accessRestricted Access

  How Does Diabetes Affect Daily Life? A Beyond-A1C Perspective on Unmet Needs

  Divya Gopisetty, Brian Levine, Nancy Liu, Phin Younge, Adam Brown, Kelly L. Close and Richard Wood

  Clinical Diabetes 2018 Apr; 36 (2): 133-137. https://doi.org/10.2337/cd17-0093

  Add to Selected Citations
• You have accessRestricted Access

  Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

  Vanita R. Aroda, Joseph R. Arulandu and Anthony J. Cannon

  Clinical Diabetes 2018 Apr; 36 (2): 138-147. https://doi.org/10.2337/cd17-0065

  Add to Selected Citations
• You have accessRestricted Access

  Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications

  Carol H. Wysham, Carlos Campos and Davida Kruger

  Clinical Diabetes 2018 Apr; 36 (2): 149-159. https://doi.org/10.2337/cd17-0064

  Add to Selected Citations
• You have accessRestricted Access

  Health Care Providers’ Perceptions of Responsibilities and Resources to Reduce Type 2 Diabetes Risk After Gestational Diabetes Mellitus

  Sumali S. Hewage, Shweta R. Singh, Claudia Chi, Jerry K.Y. Chan, Tong Wei Yew, Wee Meng Han and Joanne Yoong

  Clinical Diabetes 2018 Apr; 36 (2): 160-167. https://doi.org/10.2337/cd17-0063

  Add to Selected Citations
• You have accessRestricted Access

  Endocrinologists’ Opinions of Diabetology as a Primary Care Subspecialty

  Amber M. Healy, Jay H. Shubrook, Frank L. Schwartz, Doyle M. Cummings, Almond J. Drake and Robert J. Tanenberg

  Clinical Diabetes 2018 Apr; 36 (2): 168-173. https://doi.org/10.2337/cd17-0097

  Add to Selected Citations
• You have accessRestricted Access

  Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know

  Neil Skolnik, Debbie Hinnen, Yan Kiriakov, Melissa L. Magwire and John R. White

  Clinical Diabetes 2018 Apr; 36 (2): 174-182. https://doi.org/10.2337/cd17-0048

  Add to Selected Citations